a public good project by the
Synthesis
Company
of California

© 2026

Ke Lan | doi.page

0 works0 citations0 h-index

Ke Lan

Guangxi Medical University(CN)Shanghai Jiao Tong University(CN)Wuhan University(CN)Guangzhou Experimental Station(CN)Frontier Science Foundation(CH)Wuhan Institute of Virology(CN)Zhongnan Hospital of Wuhan University(CN)State Key Laboratory of Virology

Publications by Year

Research Areas

Viral-associated cancers and disorders, Cytomegalovirus and herpesvirus research, SARS-CoV-2 and COVID-19 Research, Herpesvirus Infections and Treatments, RNA modifications and cancer

Most-Cited Works

→ Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals(2020)2,015 cited
→ Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients(2020)1,181 cited
→ Detection of Covid-19 in Children in Early January 2020 in Wuhan, China(2020)784 cited
→ RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak(2020)602 cited
→ ddPCR: a more accurate tool for SARS-CoV-2 detection in low viral load specimens(2020)446 cited
→ Coinfection with influenza A virus enhances SARS-CoV-2 infectivity(2021)297 cited

→ Transfer of cGAMP into Bystander Cells via LRRC8 Volume-Regulated Anion Channels Augments STING-Mediated Interferon Responses and Anti-viral Immunity(2020)

280 cited

→ Aerodynamic Characteristics and RNA Concentration of SARS-CoV-2 Aerosol in Wuhan Hospitals during COVID-19 Outbreak(2020)262 cited

→ Kaposi's Sarcoma-Associated Herpesvirus-Encoded Latency-Associated Nuclear Antigen Inhibits Lytic Replication by Targeting Rta: a Potential Mechanism for Virus-Mediated Control of Latency(2004)208 cited

→ Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2(2020)198 cited